Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,775 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,528)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01046383 | Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients | terminated | Phase 3 | 16 | Immunotec Inc.INDUSTRY | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00718315 | A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. | completed | Phase 3 | 201 | Hoffmann-La RocheINDUSTRY | 1 | Jan 15, 2015 | clinicaltrials |
| NCT00049543 | Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery | completed | Phase 3 | 503 | National Cancer Institute (NCI)NIH | 1 | Jan 1, 2015 | clinicaltrials |
| NCT01955824 | A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy | completed | Phase 2 / Phase 3 | 500 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Dec 30, 2014 | clinicaltrials |
| NCT00102804 | Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 663 | Eli Lilly and CompanyINDUSTRY | 20 | Dec 29, 2014 | clinicaltrials |
| NCT01761747 | Ponatinib for Squamous Cell Lung and Head and Neck Cancers | terminated | Phase 2 / Phase 3 | 3 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer(TOPICAL) | completed | Phase 3 | 670 | University College, LondonOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT00309972 | Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery(SOCCAR) | completed | Phase 3 | 130 | University College, LondonOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT00433498 | Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer | completed | Phase 3 | 846 | University College, LondonOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT01782053 | Communicating Smoking Risks Through Graphic Warning Labels | completed | Phase 3 | 245 | University of PennsylvaniaOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00003313 | Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | completed | Phase 3 | 243 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 21, 2014 | clinicaltrials |
| NCT02283476 | The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. | unknown | Phase 3 | 200 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 6, 2014 | clinicaltrials |
| NCT02281708 | Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma | unknown | Phase 3 | 1,012 | Seoul National University HospitalOTHER | 1 | Nov 3, 2014 | clinicaltrials |
| NCT00874419 | Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation(ML20981) | completed | Phase 3 | 165 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT00321334 | Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC | completed | Phase 3 | 410 | Chinese Society of Lung CancerOTHER | 1 | Aug 6, 2014 | clinicaltrials |
| NCT00660504 | Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer | completed | Phase 3 | 300 | Marubeni Pharmaceuticals (Suzhou) Co., Ltd.INDUSTRY | 1 | Jul 18, 2014 | clinicaltrials |
| NCT00415818 | Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 148 | TransgeneINDUSTRY | 4 | Jul 16, 2014 | clinicaltrials |
| NCT00499109 | Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC | completed | Phase 3 | 275 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 3 | Jul 9, 2014 | clinicaltrials |
| NCT00148798 | Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)(FLEX) | completed | Phase 3 | 1,861 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 28 | Jun 25, 2014 | clinicaltrials |
| NCT01281787 | PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer(PRESAGE) | completed | Phase 3 | 320 | European Institute of OncologyOTHER | 1 | Jun 18, 2014 | clinicaltrials |
| NCT00907504 | Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer(ADVIGO1017) | withdrawn | Phase 3 | 0 | PfizerINDUSTRY | 0 | Jun 17, 2014 | clinicaltrials |
| NCT00004859 | Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer | terminated | Phase 3 | 589 | National Cancer Institute (NCI)NIH | 2 | Jun 2, 2014 | clinicaltrials |
| NCT00003869 | Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer | completed | Phase 3 | 186 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00047385 | National Lung Screening Trial (NLST) Screening(NLST) | completed | Phase 3 | 53,454 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00820755 | Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)(NEXT) | completed | Phase 3 | 583 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | May 5, 2014 | clinicaltrials |
| NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | completed | Phase 3 | — | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 28 | Mar 13, 2014 | clinicaltrials |
| NCT00091663 | A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 5,000 | Genentech, Inc.INDUSTRY | 1 | Mar 4, 2014 | clinicaltrials |
| NCT01028417 | Study to See if Microcoil Insertion Reduces the Rate of Open Thoracotomy for Removal of Lung Nodules | completed | Phase 3 | 60 | University of British ColumbiaOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01040780 | Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients(ICOGEN) | completed | Phase 3 | 399 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT02058433 | Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 140 | Caicun ZhouOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT00390806 | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | completed | Phase 3 | 472 | GlaxoSmithKlineINDUSTRY | 6 | Jan 20, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT00003917 | Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 3 | 4 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00041015 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 4 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00030641 | Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | Genta IncorporatedINDUSTRY | 3 | Jan 6, 2014 | clinicaltrials |
| NCT00002822 | Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | completed | Phase 3 | 400 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003364 | Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | completed | Phase 3 | 398 | London Lung Cancer GroupOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003447 | Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 3 | 630 | Istituto Nazionale per lo Studio e la Cura dei TumoriOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006048 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006049 | ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00253591 | Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 500 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002911 | Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer | completed | Phase 3 | — | ILEX Oncology Services, IncorporatedINDUSTRY | 2 | Dec 18, 2013 | clinicaltrials |
| NCT00003240 | Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | unknown | Phase 3 | 1,800 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00004100 | Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 3 | — | Istituto Nazionale per lo Studio e la Cura dei TumoriOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00022022 | Docetaxel in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | 200 | Istituto Nazionale per lo Studio e la Cura dei TumoriOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00039039 | Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer | unknown | Phase 3 | 300 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT02011997 | Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion(cVATS) | unknown | Phase 3 | 500 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT01005680 | A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 256 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 13, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jan 21, 2015source: clinicaltrials